Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,070
Closed -$85K 3502
2017
Q2
$85K Sell
11,070
-1,097
-9% -$10.3K ﹤0.01% 3134
2017
Q1
$131K Sell
12,167
-2,273
-16% -$26.4K ﹤0.01% 3032
2016
Q4
$196K Sell
14,440
-6,714
-32% -$86K ﹤0.01% 2884
2016
Q3
$279K Buy
21,154
+3,502
+20% +$52.2K ﹤0.01% 2668
2016
Q2
$278K Buy
17,652
+1,215
+7% +$19.5K ﹤0.01% 2457
2016
Q1
$228K Buy
+16,437
New +$190K ﹤0.01% 2507
2015
Q4
Sell
-20,365
Closed -$230K 2405
2015
Q3
$230K Sell
20,365
-256
-1% -$3.6K ﹤0.01% 2213
2015
Q2
$418K Sell
20,621
-794
-4% -$18.6K ﹤0.01% 2162
2015
Q1
$463K Sell
21,415
-1,970
-8% -$44.9K ﹤0.01% 2066
2014
Q4
$513K Sell
23,385
-5,044
-18% -$137K ﹤0.01% 1928
2014
Q3
$949K Buy
28,429
+3,465
+14% +$128K 0.01% 1529
2014
Q2
$1.01M Buy
24,964
+8,340
+50% +$310K 0.01% 1491
2014
Q1
$555K Buy
+16,624
New +$537K ﹤0.01% 1742

Other funds holding VRN

Raymond James & Associates's VRN Position: Q3 2017 in Review

Raymond James & Associates sold out of Veren (VRN) in Q3 2017, closing a stake of 11,070 shares — an estimated $85K sold.

Raymond James & Associates first reported a position in VRN in Q1 2014 and held it in 13 quarters. The position peaked at $1.01M in Q2 2014. 152 funds tracked by Wall St. Rank hold VRN as of Q3 2017.

  • Raymond James & Associates reported no remaining Veren position as of Q3 2017 after selling out during the quarter.
  • Raymond James & Associates sold 11,070 Veren shares in Q3 2017, an estimated $85K.
  • Raymond James & Associates first reported a position in Veren in Q1 2014 and held it in 13 quarters.
  • Raymond James & Associates's Veren position peaked at $1.01M in Q2 2014.
  • 152 funds tracked by Wall St. Rank held Veren as of Q3 2017.

Based on Raymond James & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.